AlphaBiolabs partners with Certek to drive further growth

We are delighted to announce that AlphaBiolabs is joining forces with a strategic partner going forward.

Our new partner, Certek, brings valuable expertise and resources that will support our continued growth and help accelerate key initiatives.

AlphaBiolabs will continue to operate independently within Certek. David Thomas & Rachel Davenport, who founded AlphaBiolabs over 20 years ago, will remain at the helm of the business and will also remain as shareholders.

Most importantly for our customers, our day-to-day operations, service offering, company leadership, and core culture will also remain unchanged.

About Certek

Certek is a fast-growing and international services company, specialising in testing, inspection, compliance, and assurance services across highly-regulated industries.

It partners with owner-managed businesses that are leaders in their field, and supports them to grow, innovate, and expand into new markets.

Certek’s model is built on long-term investment, respect for entrepreneurial leadership, and the retention of people, brands and processes in businesses that already have an exceptionally successful track record.

It focuses on enabling collaboration, building opportunities, and strengthening capabilities in a way that benefits customers, colleagues, and the industries they serve.

“We are delighted to welcome Alphabiolabs to the Certek family. We’ve known David and Rachel for a number of years now and have always been attracted to AlphaBiolabs due to its strong service offering, the quality of its work, and its market-leading position. We look forward to working alongside management to continue to grow AlphaBiolabs, both in the UK and internationally.” 

David Harrison, Certek

“We are so proud of what we have all achieved together as a business, which has led to this incredible opportunity to work with Certek going forwards. We can’t wait to see what the future will bring as we embark on this next exciting chapter.” 

Rachel Davenport & David Thomas, AlphaBiolabs